Quantcast

Ikonisys to Present at Rodman &Amp; Renshaw Healthcare Conference

November 4, 2008

Ikonisys, a leading provider of next-generation, cell-based diagnostic solutions, announced today that it will present at the Rodman and Renshaw 10th Annual Healthcare Conference on Tuesday, November 11 at 11:35 a.m. EST. The conference will be held at the New York Palace Hotel in New York, New York.

About Ikonisys

Ikonisys is changing the practice of diagnostic medicine through its unique CellOptics(R) platform — an innovative combination of intelligent imaging, microscopy, biology and informatics — that enables Ikonisys to deliver diagnostic test solutions that are automated, innovative and integrated. By providing “walk away” automation solutions Ikonisys enables reference labs, hospitals, research institutions and practice groups to both greatly expand their test volume capacity and standardize their diagnostic procedures. This will enhance their ability to economically deliver accurate, fast and personalized results for early cancer diagnosis and monitoring and genetic disorder screening.

In addition to automating existing FISH-based tests, the CellOptics platform enables Ikonisys to launch a stream of next-generation diagnostic tests that are based on the detection of rare cells in a practical, efficient and economical manner. These “signature” tests will include proprietary test specific reagent kits. The integration capabilities of the CellOptics platform provide for both the transfer of patient test data into a laboratory’s information systems — enabling the creation of more comprehensive patient medical records — as well as the potential to utilize these novel tests as companion diagnostics, which provides a path to more fully realize the promise of personalized medicine.

Ikonisys recently obtained FDA clearance for oncoFISH(R) her2, a fully automated microscopy application for the determination of HER2 status. Additionally, the company has FDA clearance for oncoFISH bladder, an Ikoniscope(R) application that helps in the initial diagnosis of bladder cancer and fastFISH(R) amnio, an imaging application for the Ikoniscope that provides automated identification of numerical aberrations of chromosomes associated with common birth defects.

 Media Contact: Alex Salvi Renee Viola Ikonisys 203-776-0791 Email Contact  Investor Relations Contact: Louise Mawhinney Ikonisys 203-776-0791 Email Contact

SOURCE: Ikonisys




comments powered by Disqus